Skip to main content

Advertisement

Log in

Pericarditis and Pericardial Effusion: Management Update

  • Valvular, Myocardial, Pericardial, and Cardiopulmonary Diseases (Patrick O’Gara and Akshay Desai, Section Editors)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Prompt recognition of the signs and symptoms of pericardial disease is critical so that appropriate treatments can be initiated. Acute pericarditis has a classical presentation, including symptoms, physical examination findings, and electrocardiography abnormalities. Early recognition of acute pericarditis will avoid unnecessary invasive testing and prompt therapies that provide rapid symptom relief. Non-steroidal anti-inflammatory drugs (NSAIDs) remain first-line therapy for uncomplicated acute pericarditis, although colchicine can be used concomitantly with NSAIDS as the first-line approach, particularly in severely symptomatic cases. Colchicine should be used in all refractory cases and as initial therapy in all recurrences. Aspirin should replace NSAIDS in pericarditis complicating acute myocardial infarction. Systemic corticosteroids can be used in refractory cases or in those with immune-mediated etiologies, although generally should be avoided due to a higher risk of recurrence. Pericardial effusions have many etiologies and the approach to diagnosis and therapy depends on clinical presentation. Pericardial tamponade is a life-threatening clinical diagnosis made on physical examination and supported by characteristic findings on diagnostic testing. Prompt diagnosis and management is critical. Treatment consists of urgent pericardial fluid drainage with a pericardial drain left in place for several days to help prevent acute recurrence. Analysis of pericardial fluid should be performed in all cases as it may provide clues to etiology. Consultation of cardiac surgery for pericardial window should be considered in recurrent cases and may be the first-line approach to malignant effusions, although acute relief of hemodynamic compromise must not be delayed. Constrictive pericarditis is associated with symptoms that mimic many other cardiac conditions. Thus, correct diagnosis is critical and involves identification of pericardial thickening or calcification in association with characteristic hemodynamic alterations using noninvasive and invasive diagnostic approaches. Constrictive physiology may occur transiently and resolve with medical therapy. In chronic cases, definitive therapy requires referral to an experienced surgeon for pericardiectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Watkins MW, LeWinter MM. Physiologic role of the normal pericardium. Annu Rev Med. 1993;44:171–80.

    Article  PubMed  CAS  Google Scholar 

  2. Faridah Y, Julsrud PR. Congenital absence of the pericardium revisited. Int J Cardiovasc Imag. 2002;18:67–73.

    Article  Google Scholar 

  3. Farand P, Bonenfant F, Belley-Cote EP, Tzouannis N. Acute and recurring pericarditis: More colchicine, less corticosteroids. World J Cardiol. 2010;2(12):402–7.

    Article  Google Scholar 

  4. Lotrionte M et al. International collaborative systemic review of controlled clinic trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160(4):662–70.

    Article  PubMed  CAS  Google Scholar 

  5. Maisch B, Ristic AD. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep. 2002;4(1):13–21.

    Article  PubMed  Google Scholar 

  6. Spodick DH. Risk prediction for pericarditis: who to keep in hospital? Heart. 2008;94:398–9.

    Article  PubMed  Google Scholar 

  7. Maisch B et al. Guidelines on the diagnosis and management of pericardial diseases executive summary. Euro Heart J. 2004;25:587–610.

    Article  Google Scholar 

  8. Khandaker MH et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93.

    Article  PubMed  Google Scholar 

  9. Imazio M et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for acute pericarditis (COPE) trial. Circulation. 2005;112:2012–6.

    Article  PubMed  CAS  Google Scholar 

  10. Imazio M et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (Colchicine for Recurrent Pericarditis) trial. Arch Intern Med. 2005;165:1987–91.

    Article  PubMed  CAS  Google Scholar 

  11. Artom G et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J. 2005;26:723–7.

    Article  PubMed  CAS  Google Scholar 

  12. Imazio M et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med. 2010;11(10):712–22.

    Google Scholar 

  13. Maxwell CB, Crouch MA. Intrapericardial triamcinolone for acute pericarditis after electrophysiologic procedures. Am J Health Syst Pharm. 2010;67(4):269–73.

    Article  PubMed  CAS  Google Scholar 

  14. Eisenberg MJ, de Romeral LM, Heidenreich PA, Schiller NB, Evans Jr GT. The diagnosis of pericardial effusion and cardiac tamponade by 12-lead ECG. A technology assessment. Chest. 1996;110(2):318–24.

    Article  PubMed  CAS  Google Scholar 

  15. Curtiss EI, Reddy PS, Uretsky BF, Cecchetti AA. Pulsus paradoxus: definition and relation to the severity of cardiac tamponade. Am Heart J. 1988;115(2):391–8.

    Article  PubMed  CAS  Google Scholar 

  16. Moores DWO et al. Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovasc Surg. 1995;109:546–52.

    Article  PubMed  CAS  Google Scholar 

  17. Lestuzzi C. Subxiphoid pericardial drainage for pericardial tamponade. World J Cardiol. 2010;2(9):270–9.

    Article  PubMed  Google Scholar 

  18. Liu G, Crump M, Goss PE, Dancey J, Shepherd FA. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol. 1996;14(12):3141–7.

    PubMed  CAS  Google Scholar 

  19. Thai V, Oneschuk D. Malignant pericardial effusion treated with intrapericardial bleomycin. J Palliat Med. 2007;10(2):281–2.

    Article  PubMed  Google Scholar 

  20. Kunitoh H et al. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer. 2009;100(3):464–9.

    Article  PubMed  CAS  Google Scholar 

  21. Maruyama R et al. Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trial. J Thorac Oncol. 2007;2(1):65–8.

    Article  PubMed  Google Scholar 

  22. Kralstein JMD, Frishman WMD. Malignant pericardial diseases: diagnosis and treatment. Amer Heart J. 1987;113(3):785–90.

    Article  PubMed  CAS  Google Scholar 

  23. Lima JAC, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. JACC. 2004;44:1164–71.

    PubMed  Google Scholar 

  24. Yared K et al. Multimodality imaging of pericardial disease. JACC Imaging. 2010;3:650–60.

    Article  Google Scholar 

  25. Talreja DR, Nishimura RA, Oh JK, Holmes DR. Constrictive pericarditis for the modern era: Novel critera for diagnosis in the cardiac catheterization laboratory. JACC 2008; 51(3): 315–19.

    PubMed  Google Scholar 

  26. Imazio M et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med. 2010;11(11):785–94.

    Article  Google Scholar 

  27. Ling LH et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100(13):1380–6.

    PubMed  CAS  Google Scholar 

  28. Sparano DM, Kohli P, Gulati M. A 63 year old women with a pericardial effusion, bilateral pleural effusions, and ascites: is the whole greater than the sum of its parts? Echocardiography. 2010;27:454–9.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Parker Ward MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sparano, D.M., Ward, R.P. Pericarditis and Pericardial Effusion: Management Update. Curr Treat Options Cardio Med 13, 543–555 (2011). https://doi.org/10.1007/s11936-011-0151-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-011-0151-8

Keywords

Navigation